Maitotoxin activates cation channels distinct from the receptor-activated non-selective cation channels of HL-60 cells by Musgrave, I. F. et al.
Biochem. J. (1994) 301, 437-441 (Printed in Great Britain)
Maitotoxin activates cation channels distinct from the receptor-activated
non-selective cation channels of HL-60 cells
Ian F. MUSGRAVE,* Roland SEIFERT and GOnter SCHULTZ
Institut fur Pharmakologie, Freie UniversitAt Berlin, Thielallee 69-73, D-14195 Berlin, Germany
We investigated whether maitotoxin activates non-selective
cation channels, as was recently proposed [Soergel, Yasumoto,
Daly and Gusovsky (1992) Mol. Pharmacol. 41, 487-493].
Stimulation of dibutyryl cyclic AMP-differentiated HL-60 cells
with the chemotactic peptide N-formyl-L-methionyl-L-leucyl-L-
phenylalanine (fMLP; 0.1 aM), the Ca2+-ATPase inhibitor
thapsigargin (0.1 utM) or maitotoxin (25 ng/ml) resulted in an
increase in cytoplasmic free calcium concentration ([Ca2+]1).
Unlike fMLP and thapsigargin, maitotoxin produced no increase
in [Ca2+]1 in the absence of extracellular Ca2+. The increase in
[Ca2+]i induced by fMLP was blocked by pretreatment with
pertussis toxin (100 ng/ml for 24 h) but not that induced by
maitotoxin. Similarly, the increase in [Ca2+]1 produced by fMLP
but not that produced by maitotoxin was inhibited by pre-
treatment with phorbol myristate acetate (100 ng/ml). Both
INTRODUCTION
Maitotoxin is a high-molecular-mass polyether from the marine
organism Gambierdiscus toxicus. Maitotoxin produces many
responses in a wide variety of mammalian cells, including
stimulation of hormone (Schettini et al., 1984) and neuro-
transmitter (Takahashi et al., 1983) secretion, contraction of
cardiac (Kobayashi et al., 1985) and smooth (Ohizumi and
Yasumoto, 1983) muscle, and stimulation of inositol phosphate
(Berta et al., 1986) and arachidonic acid release (Choi et al.,
1990) (for further references and reviews see Hamilton and Perez,
1987; Gusovsky and Daly, 1990). All these diverse actions are
critically dependent on stimulation of Ca2+ entry caused by
maitotoxin (see Hamilton and Perez, 1987; Gusovsky and Daly,
1990). The mechanism by which maitotoxin stimulates Ca2+
entry is poorly understood. Gusovsky and Daly (1990) have
suggested that while maitotoxin stimulates voltage-dependent
Ca2+ channels in excitable cells, this is secondary to a Ca2+_
dependent depolarization and that maitotoxin first activates
some other Ca2+ entry mechanism. Furthermore, maitotoxin also
induces Ca2+ entry in non-excitable cells (Gusovsky et al., 1990;
Columbo et al., 1992; Murata et al., 1992; Wanatabe et al.,
1993). Maitotoxin is by itself unlikely to be an ionophore
(Takahashi et al., 1983; Sladeczek et al., 1988; Murata et al.,
1992), so a possibility is that maitotoxin directly stimulates a
widely distributed Ca2+ permeant channel. Soergel et al. (1992)
have reported that maitotoxin-induced Ca2+ entry and inositol
phosphate turnover were blocked in rat insulinoma (RIN) and
human insulinoma (HIT) cells by SKF 96365, a blocker of
voltage-dependent Ca2+ channels and non-selective cation (NSC)
fMLP- and maitotoxin-induced increases in [Ca2l], were blocked
by 1-{,-[3-(4-methoxyphenyl)propoxy]-4-methoxyphenylethyl}-
IH-imidazole hydrochloride (SKF 96365) in a concentration-
dependent manner. However, the maitotoxin-induced increase in
[Ca2+]i was more sensitive to inhibition by SKF 96365 than the
fMLP-induced increase. fMLP-induced increases in [Ca2+] were
blocked by cations with Gd3+ being more effective than Cd2 ,
whereas for maitotoxin Cd2+ was more effective than Gd3+. Both
fMLP and thapsigargin stimulated quenching of Fura-2
fluorescence in the presence of extracellular Mn2 , whereas
maitotoxin produced no Mn2+ quenching. Taken together these
results suggest that maitotoxin does not stimulate the non-
selective cation channel activated by fMLP, but instead activates
Ca2+ influx by a different mechanism.
channels (Merritt et al., 1990), but not by nifedipine, a blocker of
voltage-dependent Ca2+ channels.
In order to determine if maitotoxin is indeed activating NSC
channels, we compared the efficacies of SKF 96365, Cd2+ and
Gd3+ in inhibiting Ca2+ entry induced by maitotoxin and
the chemotactic peptide N-formyl-L-methionyl-L-leucyl-L-
phenylalanine (fMLP) in differentiated HL-60 cells. HL-60 cells
were used as a model, as they are devoid of voltage-dependent
Ca2+ channels, and have a well-characterized NSC channel
(Krautwurst et al., 1992, 1993), which is activated by fMLP and
thapsigargin (Demaurex et al., 1992). We report here, on the
basis of sensitivity to SKF 96365 and inorganic blockers and
permeability to Mn2 , that maitotoxin does not activate the
fMLP-activated NSC channel of HL-60 cells, but activates Ca2+
influx through a different mechanism.
MATERIALS AND METHODS
Materials
fMLP, 4,/-phorbol 12-myristate 13-acetate, 4a-phorbol 12,13-
didecanoate and thapsigargin were obtained from Sigma Chemie
(Deisenhofen, Germany). Fura-2 acetoxymethyl ester (Fura-
2/AM) was purchased from Calbiochem (Frankfurt/Main,
Germany). Maitotoxin was obtained from Wako Pure Chemicals
Industries Ltd. (Wako, Japan). SKF 96365 was a gift from Dr.
J. E. Merritt, SmithKline Beecham (Welwyn, Herts., U.K.). All
other reagents were of analytical grade or the best available
commercial grade and obtained from standard commercial
suppliers. All buffers were adjusted to the stated pH with 1 M
NaOH. fMLP, SKF 96365, 4,/-phorbol 12-myristate 13-acetate
Abbreviations used: [Ca2+1l, cytosolic free Ca2+ concentration; db-cyclic AMP, dibutyryl cyclic AMP; DMSO, dimethyl sulphoxide; fMLP, N-formyl-L-
methionyl-L-leucyl-L-phenylalanine; Fura-2/AM, Fura-2 acetoxymethyl ester; NSC channels, non-selective cation channels; SKF 96365, 1-{f-[3-(4-
methoxyphenyl)propoxy]-4-methoxyphenylethyl}-1H-imidazole hydrochloride.
* To whom correspondence should be addressed.
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Figure 1 Effects of fMLP, thapsigargin and maitotoxin on [Ca2+]1 in db-cyclic AMP-differentiated HL-60 cells
The figure shows original tracings. Cells were loaded with Fura-2 as described in the Materials and methods section and incubated in measurement buffer containing either 1 mM Ca2+ (+ Ca2+)
or 1 mM EGTA (0 Ca2+) at 37 OC for 3 min before the addition of the stimulus. The effects of fMLP (a), thapsigargin (TG) (b) and maitotoxin (MTX) (c) on [Ca2+]i are shown. Fluorescence was
monitored on the Ratio II fluorimeter with an excitation wavelength of 340 nm and an emission wavelength of 510 nm. Similar results were seen in at least three further independent experiments
performed in duplicate or triplicate.
and thapsigargin were dissolved in dimethyl sulphoxide (DMSO)
to give stock solutions of 10 mM. Fura-2/AM was dissolved in
DMSO to give a 2 mM stock. Heavy metals were dissolved in
deionized water to give 10 mM stock solutions. Maitotoxin was
dissolved in deionized water to give a stock solution of 50 ,ug/ml.
Stock solutions were stored as aliquots at -20 'C. Further
dilutions were made in deionized water.
Cell culture
HL-60 cells were grown in suspension culture in RPMI-1640
medium supplemented with 10% (v/v) horse serum, 1 % (v/v)
non-essential amino acids, 2 mM L-glutamine, 50 units of
penicillin/ml and 50,ug of streptomycin/ml in a humidified
atmosphere with 7% CO2 at 37 'C. To induce differentiation,
HL-60 cells were seeded at a density of 1 x 106l/ml and were
cultured for 48 h in the presence of 0.2 mM dibutyryl cyclic AMP
(db-cyclic AMP) (Chaplinski and Niedel, 1982; Seifert and
Schachtele, 1988). Cells were harvested by centrifugation for
O min at 250g. Cell preparations contained more than 900%
viable cells as judged by Trypan Blue exclusion.
Measurement of cytosolic free Ca2+ concentration ([Ca2+],)
[Ca2+]1 was determined with the dye Fura-2/AM as previously
described (Schwaner et al., 1992; Seifert et al., 1992) with minor
modifications. Briefly, HL-60 cells were suspended at 1 x 107
cells/ml in loading buffer consisting of 138 mM NaCl, 6 mM
KCl, 1 mM CaCl2, 1 mM MgSO4, 1 mM Na2HPO4, 5 mM
NaHCO3, 5.5 mM glucose and 20 mM Hepes, pH 7.4,
supplemented with 1 % (w/v) BSA. Fura-2/AM was added to
give a final concentration of 4,M, and cells were incubated for
30 min at 37 'C. After this incubation period, the cells were
diluted to 0.5 x 106 cells/ml and were centrifuged for 10 min at
250 g to remove extracellular dye. The cells were then resuspended
at 2 x 106 cells/ml in measurement buffer consisting of 138 mM
NaCl, 6 mM KCl, 1 mM MgCl2, 5.5 mM glucose and 20 mM
Hepes, pH 7.4, supplemented with 100,M CaCl2, and kept at
room temperature until measurement of [Ca2+1]. This phosphate-
and bicarbonate-free buffer was required for experiments with
heavy metals, and was used throughout for purposes of con-
sistency (Merritt et al., 1989). A sample (0.5 ml) ofcell suspension
was added to acryl fluorescence cuvettes (Sarstedt, Niimbrecht,
Germany), further diluted with 1.5 ml of the measurement buffer
and CaCl2 added to give a final concentration of 1 mM.
Fluorescence was determined at 37 °C under constant stirring at
1000 rev./min, using a LS 50B dual-wavelength spectro-
fluorimeter (Perkin-Elmer, Beaconsfield, Bucks., U.K.). The
excitation wavelengths were 340 nm and 380 nm and the emission
wavelength was 510 nm. In some experiments, a Ratio II
spectrofluorimeter (Aminco, Silver Spring, MD, U.S.A.) was
used. The excitation wavelength was 340 nm, and the emission
wavelength was 510 nm. Cells were incubated for 3 min at 37 0C
before addition of stimuli. Fluorescence signals were calibrated
after lysis of the cells with 0.1 % (w/v) Triton X-100 (maximal
fluorescence) and subsequent addition of20 mM EGTA (minimal
fluorescence). [Ca2+]1 was calculated according to eqn. 5 (dual
wavelength) or eqn. 6 (single wavelength) in Grynkiewicz et al.
(1985). Ca2" entry was estimated by subtracting increases in
[Ca2+]i observed in the absence of extracellular Ca2+ from
responses in the presence of extracellular Ca2+. The value so
obtained appears to be mainly due to entry of extracellular Ca2+
with negligible contributions from other sources (see Krautwurst
et al., 1992 and the Discussion).
Measurement of Mn2+ quenching
Mn2+ quenching experiments were performed in nominally Ca2+-
free measurement buffer on the Ratio II spectrofluorimeter with
an excitation wavelength of 360 nm and an emission wavelength
of 510 nm (Merritt et al., 1989; Krautwurst et al., 1992). In some
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experiments, Mn2+ was added to nominally Ca2+-free measure-
ment buffer 1 min before the stimulus (forward method), in other
experiments Mn2+ was added to nominally Ca2+-free measure-
ment buffer 1 min after the stimulus (reverse method, see Merritt
et al., 1989). The reverse methodology is more suitable for
demonstrating slowly developing NSC-channel opening, such as
that produced by thapsigargin. Traces were calibrated against
quenching of Fura-2 fluorescence by known concentrations of
Mn2+ in cell suspensions permeabilized by Triton X-100.
RESULTS
In the presence of extracellular Ca2+ fMLP (0.1 ,uM) produced a
rapid increase in [Ca2+]i which remained elevated for several
min (Figure 1). Both thapsigargin (0.1 ,uM) and maitotoxin
(25 ng/ml) produced more slowly developing increases in [Ca2+]1
in the presence of extracellular Ca2 . In the absence of
extracellular Ca2 , fMLP (0.1 uM) produced a transient increase
in [Ca2+]i, thapsigargin (0.1 ,uM) produced a longer-lived increase
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Figure 2 Effects of SKF 96365 on the fMLP- and maitotoxin-Induced
increases In [Ca2+], In db-cyclic AMP-differentiated HL-60 cells
The figure shows original results. Cells were loaded with Fura-2 as described in the Materials
and methods section and incubated in measurement buffer containing either 1 mM Ca2+ or
1 mM EGTA (0 Ca2+) with either solvent (Control) or SKF 96365 (SKF) at 37 °C for 3 min
before the addition of the stimulus [fMLP, 0.1 ,uM (a); maitotoxin (MTX), 25 ng/ml (b)].
Fluorescence was monitored on the LS 50B spectrofluorimeter. The broken line indicates basal
Ca2+ values in the presence of 1 mM Ca2+. Similar results were seen in at least two further
experiments done in duplicate.
Figure 3 Effects of heavy metals on the fMLP- and maitotoxin-induced
Increases In [Ca2+], In db-cyclic AMP-dIfferentIated HL-60 cells
The figure shows original results. Cells were loaded with Fura-2 as described in the Materials
and methods section and incubated in measurement buffer containing either 1 mM Ca2+ or
1 mM EGTA (0 Ca2+) with either deionized water (Control) or metal ion at 37 OC for 3 min
before the addition of the stimulus [fMLP, 0.1 ,tM (a); maitotoxin (MTX), 25 ng/ml (b)].
Fluorescence was monitored on the LS 50B spectrofluorimeter. Gd3+ and Cd2+ were both at
a concentration of 10 izM. Similar results were seen in at least three further experiments done
in duplicate or triplicate.
in [Ca2+]1 which returned to basal levels after 3-4 min (see Figure
1). In contrast, maitotoxin produced no increase in [Ca2+], in the
absence of extracellular Ca2 .
The fMLP-induced increase in [Ca2+]i [404 + 39 nM (n = 2);
mean+ S.D. (n, independent experiments performed in dupli-
cate)] was almost abolished by pretreatment with pertussis toxin
[100 ng/ml; 24 h, 25 + 2 nM (n = 2)] while the maitotoxin-
induced rise was unaffected [704+ 64 nM (n = 2) versus control
587 + 66 nM (n = 2), measured 80 s after stimulus addition],
suggesting that maitotoxin does not act by stimulating pertussis
toxin-sensitive G-proteins. This is in agreement with the results
of Gusovsky et al. (1990). Similarly, the fMLP-induced increase
in [Ca2+1] [108 + 6 nM (n = 2)] was substantially inhibited
by pretreatment with 4/J-phorbol 13-myristate 12-acetate
[100 ng/ml; 28 + 13 nM (n = 2)] whereas the maitotoxin-induced
rise was unaffected [776 + 342 nM (n = 3) versus control
I
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Figure 4 Effects of SKF 96365 or heavy metals on the fMLP- and
maltotoxin-induced Increases In Ca2+ entry in db-cycllc AMP-differenftated
HL-60 cells
The figure shows the mean+S.D. from three separate experiments performed in duplicate.
Cells were loaded with Fura-2 as described in the Materials and methods section and incubated
in measurement buffer containing 1 mM Ca2+ with either solvent (control) or blocker at 37 OC
for 3 min before the addition of the stimulus [fMLP, 0.1 ,uM (U, O); maitotoxin (MTX),
25 ng/ml (0)]. Fluorescence was monitored on the LS 50B spectrofluorimeter. (a) fMLP-
induced Ca2+ entry values were calculated either 20 s (peak) or 80 s (shoulder) after addition
of stimulus. By 80 s after the addition of fMLP, the release of intracellular Ca2+ had returned
to basal. Maitotoxin-induced Ca2+ entry values were calculated 80 s after addition of maitotoxin,
by which time plateau values had been reached. (b) Differences between Ca2+ entry in the
presence of Gd3+ or Cd2+ (10 ,uM). Mean Ca2+ entry measured at 80 s was 214+112 nM
(n = 6) for fMLP (0.1 #M) and 998 +499 nM (n = 6) for maitotoxin (25 ng/ml).
720 + 275 nM (n = 3), measured 80 s after stimulus addition].
4a-Phorbol 12,13-didecanoate was without effect on the fMLP-
induced increase in [Ca2+]1 (data not shown). As phorbol ester
pretreatment can interfere with receptor coupling to
phospholipase C (Smith et al., 1987), this result suggests that
maitotoxin acts at a site beyond phospholipase C.
Both fMLP- (0.1 ,uM) and maitotoxin- (25 ng/ml) induced
increases in [Ca2+], were blocked by SKF 96365 (Figure 2). SKF
96365 was less effective at blocking the peak component of the
fMLP-induced increase in [Ca2+]1 than the 'shoulder', i.e. the
persistent response at the time when intracellular release had
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Figure 5 Effects of fMLP, thapsigargin and maltotoxin on Mn2+ quenching
of Fura-2 fluorescence in db-cyclic AMP-differentiated HL-60 cells
Fluorescence was measured with the Ratio 11 spectrofluorimeter at an excitation wavelength of
360 nm and an emission wavelength of 510 nm. The figure shows original tracings. Cells were
loaded with Fura-2 as described in the Materials and methods section and incubated in
nominally Ca2+-free measurement buffer at 37 °C for 3 min before addition of the stimulus
[fMLP (a); thapsigargin (TG) (b); maitotoxin (MTX) (c)] or solvent (Basal). After the addition
of stimulus (3 min), Mn2+ (50 ,uM) was added and the fall in fluorescence was followed for
a further 2-3 min. Similar results were seen in at least three further independent experiments.
returned to basal values (Figure 3). SKF 96365 was more
effective at blocking maitotoxin-induced [Ca2+]1 increases than
either component of the fMLP-induced increase in [Ca2+]i
(Figure 4).
Gd3+ (10l M) strongly inhibited fMLP-induced increases in
[Ca2+]1, while Cd2+ (10 ,M) was virtually ineffective (see Figures
3 and 4). As with the effects of SKF 96365, Gd3+ was more
effective on the shoulder than on the peak response. In contrast,
Gd3+ (10 #M) had no effect on the maitotoxin-induced increases
in [Ca2+]1, while Cd2+ (10l M) produced a moderate inhibition.
Both fMLP (0.1 ,uM) and thapsigargin (0.1 ,uM) produced
substantial quenching of Fura-2 fluorescence at 360 nm in the
presence of extracellular Mn2+ (Figure 5), presumably due to
entry of Mn2+ through NSC channels (Merritt et al., 1989). In
contrast, maitotoxin produced no quenching of fluorescence,
using either the reverse (see Figure 5) or the forward method (data
not shown). Using the reverse methodology with Ca2+ (i.e.
adding the stimulus to cells suspended in nominally Ca2+-free
buffer, then adding Ca2+ 2 min later, excitation wavelength
340 nm) [Ca2+]1 increased rapidly after maitotoxin application to
the concentrations achieved using the forward method (data not
shown). The concentration-response curves to fMLP for in-
creasing [Ca2+], and Mn2+ quenching were almost super-
imposable, and the sensitivities of stimulus-induced Ca2+ entry
and Mn2+ quenching to SKF 96365 were similar (data not
shown), suggesting that in these cells stimulus-induced
fluorescence quenching by Mn2+ was an index of stimulus-
induced Ca2+ entry.
DISCUSSION
Maitotoxin has been reported to stimulate Ca2+ entry in all cells
reported so far except 3T3 fibroblasts (see review by Gusovsky
and Daly, 1990), including both excitable and non-excitable cells.
In agreement with a previous report (Gusovsky et al., 1990), we
report here that maitotoxin increases [Ca2+]1 in db-cyclic AMP-
differentiated HL-60 cells. The question is, how is maitotoxin
producing this increase in [Ca2']i? As maitotoxin neither acts to
permeabilize liposomes (Takahashi et al., 1983; Murata et al.,
1992) or mitochondria (Takahashi et al., 1983) nor forms pores
in black-lipid membranes (Sladeczek et al., 1988), maitotoxin is
unlikely to be acting as an ionophore. Furthermore, in the present
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study maitotoxin-induced [Ca2+]i increases cannot be secondary
to inositol trisphosphate-induced emptying of intracellular Ca2+
stores, as in the absence of extracellular Ca2+ no increases in
[Ca2+], are seen, even though inositol trisphosphate-releasable
stores are present, as shown by the responses to fMLP and
thapsigargin (see Figure 1). This is in agreement with previous
reports (Gusovsky et al., 1990; see also Gusovsky and Daly,
1990).
Soergel et al. (1992) have suggested that maitotoxin directly
activates an NSC channel(s). In the present study the maitotoxin-
induced Ca2+ entry was inhibited by SKF 96365 (see Figures 2
and 4), which blocks both voltage-dependent Ca2+ channels and
NSC channels (Merritt et al., 1990). As HL-60 cells have an SKF
96365-inhibitable NSC channel and are devoid of voltage-
dependent Ca2+ channels (Krautwurst et al., 1992), maitotoxin
could plausibly be activatating NSC channels in these cells. This
finding is in agreement with the report of Soergel et al. (1992)
that SKF 96365, but not nifedipine, inhibits Ca2+ entry in HIT
and RIN cells.
However, the maitotoxin-induced increase in [Ca21i] was more
sensitive to SKF 96365 than the fMLP-induced increase in
[Ca2+],, raising the possibility that the mechanisms activated by
maitotoxin and fMLP are not identical. Further evidence that
maitotoxin and fMLP activate different mechanisms for in-
creasing [Ca2+]1 comes from inhibition by heavy-metal ions. In
electrophysiological studies the fMLP-activated NSC channel is
differentially inhibited by heavy-metal ions, with Gd3+ being
more potent than Cd2+ (Krautwurst et al., 1993). This was
confirmed in the present study, where the fMLP-induced increases
in Ca2+ entry are blocked by 10,M Gd3+ but not by 10,uM Cd2+
(see Figures 3 and 4). In contrast, the maitotoxin-induced
increases in Ca2+ entry were unaffected by 10 #M Gd3+, whereas
10,M Cd2+ produced a modest but significant block.
Thapsigargin-induced increases in Ca2+ entry have a sensitivity
to heavy-metal ions similar to that of fMLP (Demaurex et al.,
1992).
In the present study Ca2+ entry was estimated by subtracting
increases in [Ca2+], measured in the absence of extracellular Ca2+
from that measured in its presence, and it may be argued that the
differences in sensitivity to blockers are an artefact of this
procedure. However, the sensitivity of fMLP-induced Ca2+ entry
to SKF 96365, Gd3+ and Cd2+ at 80 s after addition of stimulus,
by which time release of Ca2+ from the intracellular store had
returned to baseline, agrees reasonably well with electro-
physiological studies (Krautwurst et al., 1993).
We studied an index of Ca2+ entry uncomplicated by Ca2+
release from intracellular stores, i.e. stimulus-induced quenching
of Fura-2 fluorescence (Merritt et al., 1989; Demaurex et al.,
1992; Krautwurst et al., 1992). However, although fMLP and
thapsigargin stimulated substantial quenching of Fura-2
fluorescence in the presence of extracellular Mn2 , maitotoxin
produced no quenching at all under a variety of protocols (see
Figure 5). This suggests that the mechanism by which maitotoxin
increases [Ca2+]1 is poorly permeable to Mn2+, especially since the
thapsigargin-induced Mn2' quenching could be clearly seen,
although the latter Ca2+ entry develops even more slowly than
that of maitotoxin and is also smaller in extent (see Figures 1 and
5). Murata et al. (1992) reported that maitotoxin induces an
influx of 54Mn2+ into HIT cells. However, the influx of 54Mn2+
was more than 20 times smaller than 45Ca2+-influx and this report
is thus consistent with our results.
Does maitotoxin produce increases in [Ca2+]1 in our HL-60
cells by blocking Ca2l efflux, rather than increasing Ca2+ entry?
This is unlikely since, as described above, the increase in [Ca2+1]
is blocked by SKF 96365, which does not affect Ca2+ efflux in the
concentrations we have used (Merritt et al., 1990). Similarly, the
inhibition of the effect of maitotoxin by low concentrations of
Cd2+ would also argue against an effect on the efflux mechanism.
Finally, maitotoxin appears to open voltage-independent
channels in HL-60 cells (D. Krautwurst, unpublished work).
Taken together these results suggest that maitotoxin is indeed
increasing Ca2+ entry in db-cyclic AMP-differentiated HL-60
cells.
To summarize, maitotoxin and fMLP activate two separate
Ca2+ entry pathways, both of which are sensitive to SKF 96365
but have different sensitivities to heavy-metal ions and different
permeabilities to Mn2+. This suggests that the maitotoxin-
activated Ca2+ entry pathway in HL-60 cells is not the receptor-
dependent NSC channel that is stimulated by fMLP and
thapsigargin. Whether maitotoxin stimulates Ca2+ entry via
activation of a novel voltage-independent Ca2+-permeant channel
or some other mechanism, remains to be determined.
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